↓ Skip to main content

An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus…

Overview of attention for article published in BMC Cancer, November 2009
Altmetric Badge

Mentioned by

policy
1 policy source

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2ndor higher line chemotherapy regarding clinical benefit - PANUSCO
Published in
BMC Cancer, November 2009
DOI 10.1186/1471-2407-9-412
Pubmed ID
Authors

Angela Märten, Moritz N Wente, Jennifer Ose, Markus W Büchler, Ingeborg Rötzer, Christiane Decker-Baumann, Irini Karapanagiotou-Schenkel, Sabine Harig, Jan Schmidt, Dirk Jäger

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Unknown 72 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 14%
Student > Master 9 12%
Student > Bachelor 6 8%
Other 5 7%
Student > Ph. D. Student 5 7%
Other 20 27%
Unknown 18 25%
Readers by discipline Count As %
Medicine and Dentistry 19 26%
Nursing and Health Professions 7 10%
Psychology 6 8%
Biochemistry, Genetics and Molecular Biology 4 5%
Social Sciences 4 5%
Other 13 18%
Unknown 20 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2018.
All research outputs
#7,536,586
of 22,994,508 outputs
Outputs from BMC Cancer
#2,095
of 8,356 outputs
Outputs of similar age
#48,840
of 166,731 outputs
Outputs of similar age from BMC Cancer
#13
of 29 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,356 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,731 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.